Detection of EGFR Mutations in cfDNA and CTCs, and Comparison to Tumor Tissue in Non-Small-Cell-Lung-Cancer (NSCLC) Patients

Lung cancer is the leading cause of cancer-related mortality worldwide. Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) therapies, based on the evaluation of EGFR mutations, have shown dramatic clinical benefits. EGFR mutation assays are mainly performed on tumor biopsies, wh...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Oncol
Autors principals: Liu, Haiyan E., Vuppalapaty, Meghah, Wilkerson, Charles, Renier, Corinne, Chiu, Michael, Lemaire, Clementine, Che, James, Matsumoto, Melissa, Carroll, James, Crouse, Steve, Hanft, Violet R., Jeffrey, Stefanie S., Di Carlo, Dino, Garon, Edward B., Goldman, Jonathan, Sollier, Elodie
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2020
Matèries:
Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7578230/
https://ncbi.nlm.nih.gov/pubmed/33117705
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.572895
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars